| 12503463 |
Aliphatic acid amide derivative |
Yuki Fujii, Masayuki Sakuma, Yoshinori AIHARA, Jeremy Besnard |
2025-12-23 |
|
| 12304909 |
Compounds and their use in therapy |
Edward William Tate |
2025-05-20 |
|
| 12180213 |
Substituted pyrazoles showing serotonin 5-HT receptor activity |
Hidefumi Yoshinaga, Yohei Ikuma, Junya Ikeda, Satoshi ADACHI, Harunobu MITSUNUMA +2 more |
2024-12-31 |
|
| 12060355 |
Compounds for use in the treatment of fascioliasis |
John M. Gardner |
2024-08-13 |
$234,312,000 |
| 11786528 |
Pyrazolopyrimidine compounds as adenosine receptor antagonists |
Adrian Michael SCHREYER, Stephanie VERSLUYS |
2023-10-17 |
$5,763,000 |
| 11466007 |
Substituted lactams showing serotonin 5-HT receptor activity |
Hidefumi Yoshinaga, Yohei Ikuma, Junya Ikeda, Satoshi ADACHI, Harunobu MITSUNUMA +2 more |
2022-10-11 |
|
| 11466011 |
Compounds and their use as inhibitors of N-myristoyl transferase |
Edward William Tate, Robin John Leatherbarrow, Jennie Ann Hutton, James Antony Brannigan |
2022-10-11 |
|
| 11339151 |
Aliphatic acid amide derivative |
Yuki Fujii, Masayuki Sakuma, Yoshinori AIHARA, Jeremy Besnard |
2022-05-24 |
|
| 11046700 |
Substituted imidazo[1,2-a]pyrazines, pyrazolo[1,5-c]pyrimidines, pyrazolo[1,5-a]pyridines, and purines for the treatment of schistosomiasis |
John M. Gardner |
2021-06-29 |
$135,073,000 |
| 10759804 |
Compounds and their use as inhibitors of N-myristoyl transferase |
Edward William Tate, Robin John Leatherbarrow, Jennie Ann Hutton, James Antony Brannigan |
2020-09-01 |
|
| 10745401 |
Condensed lactam derivative |
Hidefumi Yoshinaga, Yohei Ikuma, Junya Ikeda, Satoshi ADACHI, Harunobu MITSUNUMA +2 more |
2020-08-18 |
|
| 10577363 |
Substituted piperidine compounds |
Lorna Helen Mitchell, Richard Chesworth, Megan Foley, Kevin Wayne Kuntz, James Edward John Mills +1 more |
2020-03-03 |
$33,780,000 |
| 9447116 |
Inhibitors of HIV replication |
Iain Brian Gardner, Karl Richard Gibson, David Cameron Pryde, Florian Wakenhut |
2016-09-20 |
|
| 8809363 |
Inhibitors of HIV replication |
Iain Brian Gardner, Karl Richard Gibson, David Cameron Pryde, Florian Wakenhut |
2014-08-19 |
|
| 8772343 |
Chemical compounds |
Alan Daniel Brown, Russell Andrew Lewthwaite, Manuel Perez-Pacheco, David James Rawson, Robert Ian Storer +1 more |
2014-07-08 |
$296,854,000 |
| 8685977 |
Chemical compounds |
Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David S. Millan, Manuel Perez Pacheco +6 more |
2014-04-01 |
$235,129,000 |
| 8592629 |
Sulfonamide derivatives as Nav 1.7 inhibitors |
Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh, David S. Millan +6 more |
2013-11-26 |
$220,822,000 |
| 8097621 |
Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors |
David Brown, Kevin Dack, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell +2 more |
2012-01-17 |
$303,869,000 |
| 7943628 |
Pyrimidine derivatives |
Charlotte Alice Louise Lane, Charles Eric Mowbray |
2011-05-17 |
$649,869,000 |
| 7902195 |
Pyridine [3,4-b] pyrazinones |
Robert Owen Hughes, David Brown, Dafydd Rhys Owen, Michael John Palmer, Christopher Phillips +12 more |
2011-03-08 |
|
| 7572799 |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
David Brown, Kevin Neil Dack, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell +2 more |
2009-08-11 |
$271,217,000 |
| 7569572 |
Pyrazolo[4,3-D]pyrimidines |
David Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Dafydd Rhys Owen +4 more |
2009-08-04 |
$282,206,000 |
| 7262192 |
Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors |
David Brown, David Nathan Abraham Fox, Ian Roger Marsh, Andrew Ian Morrell, Michael John Palmer +1 more |
2007-08-28 |
$346,493,000 |
| 6914160 |
Oxytocin inhibitors |
Duncan Robert Armour, Paul Edwards, David Ellis, David Hepworth, Mark Llewellyn Lewis +1 more |
2005-07-05 |
$351,280,000 |
| 6376526 |
Triazole antifungal agents |
Peter Stephenson |
2002-04-23 |
$303,971,000 |
